ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Mr. Michael Farrell es el Chairman of the Board de Resmed Inc, se unió a la empresa desde 2005.
¿Qué tal es el rendimiento del precio de la acción RSMDF?
El precio actual de RSMDF es de $25.04, ha disminuido un 0.35% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Resmed Inc?
Resmed Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Resmed Inc?
La capitalización bursátil actual de Resmed Inc es $3.6B
¿Es Resmed Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 19 analistas han realizado calificaciones de análisis para Resmed Inc, incluyendo 4 fuerte compra, 12 compra, 6 mantener, 0 venta, y 4 fuerte venta